Effect of intravesical botulinum toxin injection on symptoms of autonomic dysreflexia in a patient with chronic spinal cord injury: a case report
The Journal of Spinal Cord Medicine, 2019 · DOI: 10.1080/10790268.2017.1322738 · Published: November 1, 2019
Simple Explanation
Autonomic dysreflexia is a serious complication of spinal cord injury that causes high blood pressure and other symptoms. This case report explores a new treatment option. The patient in this study suffered from chronic cervical spinal cord injury and experienced autonomic dysreflexia. Traditional treatments were ineffective. An intravesical botulinum toxin injection was administered to the patient to control bladder spasms and mechanical irritation. The patient's blood pressure stabilized, and the underlying lung cancer could be resected.
Key Findings
- 1Intravesical botulinum toxin injection can effectively control symptoms of autonomic dysreflexia in patients with chronic SCI.
- 2The botulinum toxin injection led to stabilized blood pressure, allowing for a previously impossible lung cancer resection.
- 3The improvement in autonomic dysreflexia symptoms lasted for more than 6 months after the botulinum toxin injection.
Research Summary
Practical Implications
Treatment Option
Intravesical botulinum toxin injection may be a viable treatment option for autonomic dysreflexia in patients with chronic SCI, especially when conservative management fails.
Pre-Surgical Intervention
Botulinum toxin injections can stabilize blood pressure to allow for necessary surgeries that were previously too risky due to uncontrolled autonomic dysreflexia.
Further Research
Large, prospective trials are needed to further evaluate the efficacy and safety of botulinum toxin for autonomic dysreflexia in SCI patients.
Study Limitations
- 1Single case study limits generalizability.
- 2Long-term effects of botulinum toxin injection not fully explored.
- 3Patient had underlying conditions (diabetes, hypertension, adrenal masses) that may have influenced the results.